64.4K
Downloads
289
Episodes
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
Episodes
Tuesday Jul 28, 2020
Tuesday Jul 28, 2020
The ongoing COVID-19 pandemic caused by SARS-CoV-2 is an international public health issue and patients with cancer consistently demonstrate poorer...
The post The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation appeared first on VJHemOnc.
Thursday Jul 16, 2020
Thursday Jul 16, 2020
The acute myeloid leukemia (AML) field has witnessed rapid evolution of late, with exciting developments in strategies for the treatment...
The post The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML appeared first on VJHemOnc.
Tuesday Jul 07, 2020
Tuesday Jul 07, 2020
Acute lymphoblastic leukemia (ALL) is a malignant disorder of lymphoid progenitor cells affecting both adults and children. With a greater...
The post Key updates in ALL at EHA 2020 appeared first on VJHemOnc.
Friday Jul 03, 2020
Friday Jul 03, 2020
The multiple myeloma field is rapidly evolving, with exciting developments in strategies for the treatment of smoldering myeloma, relapsed/refractory (R/R)...
The post The Myeloma Sessions: smoldering myeloma, MRD evaluation, R/R disease & transplant-eligible patients appeared first on VJHemOnc.
Tuesday Jun 02, 2020
Tuesday Jun 02, 2020
Systemic mastocytosis (SM) is a rare hematological neoplasm. Advanced systemic mastocytosis can be sub-classified into either aggressive SM, SM with...
The post Systemic mastocytosis: current landscape, novel agents and COVID-19 appeared first on VJHemOnc.
Wednesday Apr 22, 2020
Wednesday Apr 22, 2020
Assessment of treatment efficacy in acute myeloid leukemia (AML) is highly relevant for further treatment stratification. In clinical trials, measurable...
The post MRD assessment in AML: incorporation into clinical practice appeared first on VJHemOnc.
Tuesday Apr 14, 2020
Tuesday Apr 14, 2020
The management of multiple myeloma presents many clinical challenges. The additional layer of complication COVID-19 places on patients and clinicians...
The post Myeloma management in the COVID-19 era appeared first on VJHemOnc.
Thursday Apr 02, 2020
Thursday Apr 02, 2020
Novel combinations work well for many patients suffering from chronic lymphocytic leukemia (CLL), but there is a subset of patients...
The post CAR-T in the CLL space appeared first on VJHemOnc.
Thursday Apr 02, 2020
Thursday Apr 02, 2020
CAR-T cell therapy offers a potentially paradigm-changing new treatment for multiple myeloma. Additionally, CAR-T toxicity is may be more manageable...
The post CAR T-cell therapy & multiple myeloma: past, present & future appeared first on VJHemOnc.
Thursday Apr 02, 2020
Thursday Apr 02, 2020
A deeper understanding of the characteristics, features and interactions at play in the tumor microenvironment has given great insight into...
The post Harnessing the tumor microenvironment in lymphoma therapy appeared first on VJHemOnc.